[Floctafenine in the treatment of painful syndromes of neurologic interest].
The clinical results obtained with phloctaphenin in an "open" study comprising cases of real neuralgia and spinal radicular pain syndromes and in a "double-blind" study comparing the preparation with a placebo, and involving algico-vasomotor syndromes of the face, are reported. The results obtained confirm the antalgic power of phloctaphenin for by the third day, subacute or chronic pain syndromes already presented a significant improvement in simptomatology, while in algico-vasomotor syndromes of the face, the treatment proved effective in eliminating pain attacks.
D000284:Administration, Oral; D001416:Back Pain / Q000188:drug therapy; D020968:Brachial Plexus Neuritis / Q000188:drug therapy; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D010919:Placebos; D011843:Radiculopathy / Q000188:drug therapy*; D012585:Sciatica / Q000188:drug therapy; D013706:Temporomandibular Joint Dysfunction Syndrome / Q000188:drug therapy*; D014277:Trigeminal Neuralgia / Q000188:drug therapy; D062367:ortho-Aminobenzoates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010919:Placebos; D062367:ortho-Aminobenzoates
La floctafenina nel trattamento di sindromi dolorose di interesse neurologico.